LCLaura Caltana

Laura Caltana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Laura Caltana has a total of 38 co-authors. Here are the top co-authors by number of shared publications:

  • Alicia Brusco

    Instituto de Biología Celular y Neurociencia "Prof. E. De Robertis" (UBA-CONICET). Facultad de Medicina, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina

    3 shared publications
  • Lourdes Cáceres

    Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Química Analítica y Fisicoquímica, Cátedra de Química General e Inorgánica, Argentina; Universidad de Buenos Aires, CONICET, Instituto de Bioquímica y Medicina Molecular (IBIMOL), Facultad de Farmacia y Bioquímica, Argentina

    2 shared publications
  • Mariana Garcés

    Universidad de Buenos Aires, Instituto de Bioquímica y Medicina Molecular Prof. Alberto Boveris (IBIMOL-UBA-CONICET), Buenos Aires, Argentina

    2 shared publications
  • Natalia D. Magnani

    Universidad de Buenos Aires. Instituto de Bioquímica y Medicina Molecular (IBIMOL UBA-CONICET), Facultad de Farmacia y Bioquímica

    2 shared publications
  • Pablo Evelson

    Universidad de Buenos Aires. Instituto de Bioquímica y Medicina Molecular (IBIMOL UBA-CONICET), Facultad de Farmacia y Bioquímica

    2 shared publications
  • Sofía Reynoso

    Universidad de Buenos Aires, Instituto de Bioquímica y Medicina Molecular Prof. Alberto Boveris (IBIMOL-UBA-CONICET), Buenos Aires, Argentina

    2 shared publications

Latest Publications

  • Trigeminal neuroplasticity after pulpitis and oral administration of paracetamol in rats

    by Mariela C Canzobre, Yamila Boix, Maria E Miyashiro, Alejandra R Paganelli, Laura R Caltana, Hugo Ríos

    Experimental stimulation of dental pulp nociceptors induces plastic changes in the trigeminal subnucleus caudalis (Vc) through increased intracellular calcium levels and discharge of nociceptive afferent fibers. Acetaminophen (paracetamol) is a potent and selective inhibitor of COX-2 within the central nervous system (CNS) and may act in association with the cannabinoid system and the descending serotonergic pathway. Aim: In this context, the main objective of this study is to analyze the plastic changes induced by paracetamol in the nociceptive circuit of the Vc following unilateral dental pulp inflammation (pulpitis) in rats. Material and Method: Twenty-one female Wistar rats, 50 days old, were divided into three groups. In the experimental group 1 (EG1), a unilateral pulpitis was induced in the left mandibular first molar, and animals received no further treatment. In group 2 (EG2), the procedure was the same as in EG1, but 48 h later, animals received paracetamol in 3 daily doses (300 mg/kg each) every 4 h for 2 days. The control group (CG) received no treatment. After euthanasia, liver, hemimandibles and brainstem samples were analyzed. The results were analyzed using Student’s t-test or ANOVA (p<0.05). Results: 5-hydroxytryptamine transporter (5HT-T) analysis in the ipsilateral Vc demonstrated that paracetamol administration increased plexus length and varicosity density compared with EG1 and CG (p<0.05). Paracetamol also increased cannabinoid CB1 receptor (CB1r) expression (p<0.05), and decreased the number of calbindin D28K positive projection neurons (p<0.05). Conclusion: Following experimental pulpitis, oral administration of paracetamol induces plastic changes in the serotonergic and endocannabinoid systems within the Vc. This plasticity is reflected by a reduced number of fusiform calbindin D28K projection neurons in lamina I, associated with modulation of orofacial nociceptive processing.

  • Airborne particulate matter exposure impairs lung redox metabolism involved in tissue damage repair mechanisms

    by Sofía Reynoso, Laura Caltana, Agustina Freire, Mariana Garcés, Lourdes Cáceres, Florencia Sarno, Timoteo Marchini, Pablo Evelson, Natalia Magnani

  • Impaired lung redox metabolism and cardiac mitochondrial function aggravates myocardial infarction in a mice model of chronic exposure to urban air pollution

    by Timoteo Marchini, Natalia Magnani, Mariana Garcés, Kelly Jazmín, Mariela Paz, Lourdes Cáceres, Romina Lasagni Vitar, Valeria Calabró, Laura Caltana, Mario Contin, et al.

  • Neuronal and synaptic morphological alterations in the hippocampus of cannabinoid receptor type 1 knockout mice

    by Delia Soriano, Marina Vacotto, Alicia Brusco, Laura Caltana

    Cannabinoid receptor type 1 (CB1R) modulates synaptic activity and is widely distributed in brain areas such as the hippocampus, cerebellum, cerebral cortex, and striatum, among others. CB1R is involved in processes such as memory, learning, motor coordination, and mood. Genetic deletion of CB1R causes behavioral alterations. In this work, we evaluated neuronal morphology and synaptic structure in the hippocampus of adult male CB1R knockout mice (CB1R−/−). Morphological changes in the CB1R−/− hippocampus evidenced a decrease in the expression of cytoskeletal proteins neurofilaments 160 KDa, neurofilaments 200 KDa, and microtubule‐associated protein 2. CA1 neurons showed decreased arborization and changes in synaptic structure such as lower thickness of postsynaptic density and a reduction in synaptophysin levels. Results obtained in the present work provide evidence of the participation of CB1R in the establishment of neuronal structure and networks that could have an important role in neuronal plasticity. In addition, these changes observed in CB1R−/− could be correlated with behavioral alterations reported.


  • Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice

    by Laura Caltana, Trinidad Maria Saez, María Paula Aronne, Alicia Brusco

    Brain ischemia produces neuronal cell death and the recruitment of pro‐inflammatory cells. In turn, the search for neuroprotection against this type of insult has rendered results involving a beneficial role of endocannabinoid receptor agonists in the Central Nervous System. In this work, to further elucidate the mechanisms associated to this neuroprotective effect, focal brain ischemia was generated by middle cerebral artery occlusion (MCAo) in C57Bl/6 mice. Three, 24 and 48 h after MCAo, animals received CB1R agonist ACEA (1 mg/kg), CB1R antagonist AM251 (1 mg/kg) or vehicle. To assess motor activity, neural deficit scores and motor tests were performed 1 day before and 3, 7, 14, 21, and 28 days after MCAo. At 7 and 28 days post lesion, cytoskeleton structure, astroglial and microglial reaction, and alterations in synapsis were studied in the cerebral cortex. ACEA treatment reduced astrocytic reaction, neuronal death, and dendritic loss. In contrast, AM251 treatment increased these parameters. Motor tests showed a progressive deterioration in motor activity in ischemic animals, which only ACEA treatment was able to counteract. Our results suggest that CB1R may be involved in neuronal survival and in the regulation of neuroprotection during focal cerebral ischemia in mice. image ACEA improved the motor activity affected by the middle cerebral artery occlusion. At histologic level, ACEA preserved the neuronal cytoarchitecture, decreased the astroglial and microglial reaction.


  • Further Evidence for the Neuroplastic Role of Cannabinoids: A Study in Organotypic Hippocampal Slice Cultures

    by Laura Romina Caltana, Bernd Heimrich, Alicia Brusco

    Endocannabinoid receptors CB1R and CB2R are present in the CNS and modulate synaptic activity. By using an in vitro model, two concentrations of CB1R agonist ACEA at 0.5 and 5 μM doses and CB1R antagonist AM251 at 1 and 10 μM doses were administered in organotypic slice cultures of mouse hippocampus, and their effects on neurons and glial cells were analyzed at different time points. Exposure to low concentrations of ACEA (0.5 μM) did not seem to affect tissue organization, neuronal morphology, or glial response. In contrast, at a higher concentration of ACEA, many neurons in the dentate gyrus exhibited strong caspase-3 immunoreactivity. After treatment with AM251, we observed an increase in caspase-3 immunoreactivity and a downregulation of CB1R expression. Results show that long-term hippocampal slice cultures respond to both CB1R activation and inactivation by changing neuronal protein expression patterns. In the present study, we demonstrate that CB1R agonist ACEA promotes alterations in the neuronal cytoskeleton as well as changes in CB1R expression in organotypic hippocampal slice cultures, and that CB1R antagonist AM251 promotes neuronal death and astroglial reaction.


  • Open Access

    Oleanolic acid: a promising neuroprotective agent for cerebral ischemia

    by Caltana Laura, NietoMaría Luisa, Brusco Alicia

    Neural Regen Res, Official publication of Publishing House of Neural Regeneration Research China Association of Rehabilitation Medicine,China